Atlas Trials

Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke

Clinical trial NCT04950790 · UNKNOWN

Trial details

NCT number
NCT04950790
Sponsor
Peking University Third Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Ischemic Stroke
Start date
2018-04-01
Primary completion
2021-12-01
Enrollment
480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.